Potential recurrence of COVID-19 in a healthcare professional : SARS-CoV-2 genome sequencing confirms contagiousness after re-positivity
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved..
Re-positivity of SARS-CoV-2 tests is widely reported, raising discussion about guidance for patient discharge and ending isolation. The unsuccessful recovery of replication-competent virus and/or absence of secondary cases has suggested that re-positive patients are not contagious. This study reports SARS-CoV-2 re-positivity in a healthcare professional 16 days after three negative tests, with viral genome sequencing supporting contagiousness leading to secondary cases.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:112 |
---|---|
Enthalten in: |
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases - 112(2021) vom: 02. Nov., Seite 318-320 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Correia, Ana M [VerfasserIn] |
---|
Links: |
---|
Themen: |
COVID-19 |
---|
Anmerkungen: |
Date Completed 03.12.2021 Date Revised 14.12.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.ijid.2021.09.035 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM330893017 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM330893017 | ||
003 | DE-627 | ||
005 | 20231225212253.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.ijid.2021.09.035 |2 doi | |
028 | 5 | 2 | |a pubmed24n1102.xml |
035 | |a (DE-627)NLM330893017 | ||
035 | |a (NLM)34547489 | ||
035 | |a (PII)S1201-9712(21)00739-6 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Correia, Ana M |e verfasserin |4 aut | |
245 | 1 | 0 | |a Potential recurrence of COVID-19 in a healthcare professional |b SARS-CoV-2 genome sequencing confirms contagiousness after re-positivity |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 03.12.2021 | ||
500 | |a Date Revised 14.12.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved. | ||
520 | |a Re-positivity of SARS-CoV-2 tests is widely reported, raising discussion about guidance for patient discharge and ending isolation. The unsuccessful recovery of replication-competent virus and/or absence of secondary cases has suggested that re-positive patients are not contagious. This study reports SARS-CoV-2 re-positivity in a healthcare professional 16 days after three negative tests, with viral genome sequencing supporting contagiousness leading to secondary cases | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a Genome sequencing | |
650 | 4 | |a Infectivity | |
650 | 4 | |a Re-positivity | |
650 | 4 | |a SARS-CoV-2 | |
700 | 1 | |a Borges, Vítor |e verfasserin |4 aut | |
700 | 1 | |a Isidro, Joana |e verfasserin |4 aut | |
700 | 1 | |a Lima, Ana R |e verfasserin |4 aut | |
700 | 1 | |a Fernandes, Alberto |e verfasserin |4 aut | |
700 | 1 | |a Godinho, Maria Leonor |e verfasserin |4 aut | |
700 | 1 | |a Duarte, Sílvia |e verfasserin |4 aut | |
700 | 1 | |a Ferrão, José |e verfasserin |4 aut | |
700 | 1 | |a Vieira, Luís |e verfasserin |4 aut | |
700 | 1 | |a Gomes, João P |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases |d 1998 |g 112(2021) vom: 02. Nov., Seite 318-320 |w (DE-627)NLM094730857 |x 1878-3511 |7 nnns |
773 | 1 | 8 | |g volume:112 |g year:2021 |g day:02 |g month:11 |g pages:318-320 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ijid.2021.09.035 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 112 |j 2021 |b 02 |c 11 |h 318-320 |